Term Description

This protocol provides instructions for drawing, processing and storing blood according to the National Health and Nutrition Examination Survey (NHANES) methods. As there are no standard assays for C-peptide, the protocol also provides basic guidelines to aid comparability among different studies. Although all three are valuable stand alone measures and all should be collected if resources are available, the Diabetes Working Group recommends that investigators prioritize Insulin 1st, C-peptide 2nd and Proinsulin 3rd. This is because results from the Insulin bioassay can be combined with results from Fasting Plasma Glucose bioassay to derive the homeostatic model assessment (HOMA) of insulin resistance and pancreatic beta cell function. The Diabetes Working Group notes that while it is not the preferred method, the C-peptide Assay can be performed on individuals who have not met the fasting requirements.

Reference Information

TypeSourceReference
ArticleConsensus measures for Phenotypes and ExposuresAmerican Diabetes Association. (2010). Diagnosis and classification of diabetes mellitus. Diabetes Care, 33 (Supplement 1), S11 - S61.
CitationConsensus measures for Phenotypes and ExposuresCenters for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Questionnaire. Laboratory Procedures Manual. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2007.
ArticleConsensus measures for Phenotypes and ExposuresMarques, RG, Fontaine, MJ, & Rogers, J. (2004). C-peptide - much more than a byproduct of insulin biosynthesis. Pancreas, 29(3), 231-238.

Panel Hierarchy

Details for each LOINC in Panel LHC-Forms

LOINCNameR/O/CCardinalityExample UCUM Units
62803-2PhenX - fasting C-peptide assay for residual beta cell function protocol 141201
Indent66164-5Did you eat or drink anything other than plain water after 11:30 last night?
Indent66165-2When did you last eat or drink anything other than plain water?
Indent66166-0Have you had any of the following since {insert time from 1 here}? Coffee or tea with cream and sugar? [Include milk or non-dairy creamers.]
Indent66167-8If Yes, record date
Indent66168-6Have you had any of the following since {insert time from 1 here}? Alcohol, such as beer, wine, or liquor?
Indent66169-4If Yes, record date
Indent66170-2Have you had any of the following since {insert time from 1 here}? Gum, breath mints, lozenges, or cough drops, or other cough or cold remedies?
Indent66171-0If Yes, record date
Indent66172-8Have you had any of the following since {insert time from 1 here}? Antacids, laxatives, or anti-diarrheals?
Indent66173-6If Yes, record date
Indent66182-7Have you had any of the following since {insert time from 1 here}? Dietary Supplements such as vitamins and minerals? [Include multivitamins and single nutrient supplements.]
Indent66183-5If Yes, record date
Indent66177-7Do you have hemophilia?
Indent66178-5Have you received cancer chemotherapy in the past four weeks or do you anticipate such therapy in the next four weeks?
Indent66179-3Exclusion Criteria
Indent66180-1Was blood drawn?
Indent66181-9Was full sample obtained?
Indent8251-1Service comment
Indent8251-1Service comment
Indent66200-7Repeatability of the assay{ratio}
Indent66201-5Coefficient of variation for the assay{CV}
Indent66202-3Was the participant fasting?

LOINC Names Get Info

Fully-Specified Name
PhenX - fasting C-peptide assay for residual beta cell function protocol 141201:-:Pt:^Patient:-:PhenX
Long Common Name
PhenX - fasting C-peptide assay for residual beta cell function protocol 141201
Short Name
Fasting C-peptide proto

Part Model Get Info

  • Component
    PhenX - fasting C-peptide assay for residual beta cell function protocol 141201
    LP112340-7
    • Analyte
      PhenX - fasting C-peptide assay for residual beta cell function protocol 141201
      LP112340-7
      • Component Numerator
        PhenX - fasting C-peptide assay for residual beta cell function protocol 141201
        LP112340-7
        • Component Numerator Core
          PhenX - fasting C-peptide assay for residual beta cell function protocol 141201
          LP112340-7
        • Component Numerator Core Suffix
          NULL
           
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    -
    LP6769-6
  • Time
    Pt
    LP6960-1
  • System
    ^Patient
    LP310005-6
    • System Core
      NULL
       
    • Super System
      Patient
      LP6985-8
  • Scale
    -
    LP7747-1
  • Method
    PhenX
    LP95333-8

Survey Question

PX141201

Basic Attributes

Class
PANEL.PHENX
Type
Clinical
First Released
Version 2.36
Last Updated
Version 2.81 (MIN)
Change Reason
Release 2.81: Status: Changing PhenX Concept from Status = Trial to Active; Previous Releases: Updated the PhenX ID from "PhenX.<ID>" to "PX<ID>" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.; Added the PhenX protocol ID to the Component to clearly define the protocol version for which this panel is based upon.
Panel Type
Panel

Member of these Panels

LOINCLong Common Name
62787-7PhenX domain - Diabetes

Language Variants Get Info

TagLanguageTranslation
el-GRGreek (Greece)PhenX - προσδιορισμός C-πεπτιδίου νηστείας για υπολειμματική λειτουργία β-κυττάρων πρωτόκολλο 141201:-:Pt:^Ασθενής:-:PhenX
Synonyms: - C PANEL.PHENX PHENX PhenX - προσδιορισμός C-πεπτιδίου νηστείας για υπολειμματική λειτουργία β-κυττάρων πρωτόκολλο 141201 Pt Ασθενής Λειτουργία Πεπτίδιο C
es-MXSpanish (Mexico)PhenX: ensayo de péptido C en ayunas para el protocolo de función residual de células beta 141201:-:Punto temporal:^ Paciente:-:PhenX
it-ITItalian (Italy)PhenX - test peptide C a digiuno per la funzione delle cellule beta residue, protocollo:-:Pt:^Paziente:-:PhenX
Synonyms: Panel PhenX paziente PhenX Punto nel tempo (episodio)
ru-RURussian (Russian Federation)PhenX - голодание С-пептид анализ на остаточную бета клеток функцию протокол:-:ТчкВрм:^Пациент:-:PhenX
Synonyms: C белок Точка во времени;Момент
zh-CNChinese (China)PhenX - 残余 beta 细胞功能空腹 C-肽检测方案 141201:-:时间点:^患者:-:PhenX
Synonyms: B C 型;丙;丙型 Consensus measures for Phenotypes and eXposures;PhenX;暴露;接触;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标 Consensus measures for Phenotypes and eXposures;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标 FCN PhenX - 残余 beta 细胞功能空腹(禁食、断食、不吃饭) C-肽检测方案 141201;PhenX - 残余(残存) beta 细胞(β细胞)功能空腹 C-肽(C肽)检测方案;Consensus measures for Phenotypes and eXposures;PhenX;暴露;接触;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标 β 前胰岛素 C 肽;胰岛素原 C 肽 医嘱套餐 医嘱套餐类 医嘱套餐组 医嘱组 医嘱组.PhenX;组套(组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目).PhenX;Consensus measures for Phenotypes and eXposures;PhenX;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标;PhenX 医嘱组 医嘱组合 医嘱组合类 医嘱组套 医嘱组套类 医嘱组类 医疗服务对象;客户;病人;病患;病号;超系统 - 病人 多重;多重型;多重标尺类型;多重精度类型 套餐 套餐医嘱 套餐医嘱组 套餐医嘱组类 实验室医嘱套餐 实验室医嘱套餐类 实验室医嘱组 实验室医嘱组合类 实验室医嘱组套 实验室医嘱组套类 实验室套餐医嘱组 实验室套餐医嘱组类 实验室检验项目医嘱组合类 实验室检验项目组合类 时刻;随机;随意;瞬间 检验医嘱组合类 检验项目医嘱组合类 检验项目组合类 组 组合 组合医嘱 组合类 组套 缩氨酸 贝塔

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=62803-2
Questionnaire definition
https://fhir.loinc.org/Questionnaire/?url=http://loinc.org/q/62803-2